Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.

By D. J. Drucker. Cell Metabolism, 2018

1,744 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Physiology, Surgery

View Paper: https://www.semanticscholar.org/paper/5d4d75042891834607407461fbb1843e150b9907

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Dandan Zhang
2. Ziwei Cui
3. Rui-Juan Guo
4. Xiao-Fu Huang
5. Mei Han
6. Peng Kong

Citations in the corpus

• Inflammation and atherosclerosis: signaling pathways and therapeutic intervention (2022, background): “These findings and subsequent evidence suggest that GLP-1 inhibits gastric emptying, food intake, and glucagon secretion supporting to development GLP-1 receptor agonists (GLP-1 RA) for the treatment of type 2 diabetes mellitus (T2DM).(325) GLP-1 RAs mainly include exenatide, liraglutide, albiglutid”